Its anti-cancer effects have been demonstrated on a panel of human tumor cell lines, including bladder, lung, breast, and colon cancer cells, by modulating epigenetic as well as non-epigenetic pathways involving interactions with the Akt/MAPK and the Nrf2/ARE signaling pathways [19]. This evidence concerns the gene AKT1 and neoplasm.